Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver.
The transcription factor Nrf2 regulates expression of multiple cellular defence proteins through the antioxidant response element (ARE). Nrf2-deficient mice (Nrf2(-/-)) are highly susceptible to xenobiotic-mediated toxicity, but the precise molecular basis of enhanced toxicity is unknown. Oligonucleotide array studies suggest that a wide range of gene products is altered constitutively, however no equivalent proteomics analyses have been conducted. To define the range of Nrf2-regulated proteins at the constitutive level, protein expression profiling of livers from Nrf2(-/-) and wild type mice was conducted using both stable isotope labelling (iTRAQ) and gel electrophoresis methods. To establish a robust reproducible list of Nrf2-dependent proteins, three independent groups of mice were analysed. Correlative network analysis (MetaCore) identified two predominant groups of Nrf2-regulated proteins. As expected, one group comprised proteins involved in phase II drug metabolism, which were down-regulated in the absence of Nrf2. Surprisingly, the most profound changes were observed amongst proteins involved in the synthesis and metabolism of fatty acids and other lipids. Importantly, we show here for the first time, that the enzyme ATP-citrate lyase, responsible for acetyl-CoA production, is negatively regulated by Nrf2. This latter finding suggests that Nrf2 is a major regulator of cellular lipid disposition in the liver.
Kitteringham
Neil R
NR
MRC Centre for Drug Safety Science, School of Biomedical Sciences, University of Liverpool, Liverpool, Merseyside, United Kingdom. neilk@liv.ac.uk
Abdullah
Azman
A
Walsh
Joanne
J
Randle
Laura
L
Jenkins
Rosalind E
RE
Sison
Rowena
R
Goldring
Christopher E P
CE
Powell
Helen
H
Sanderson
Christopher
C
Williams
Samantha
S
Higgins
Larry
L
Yamamoto
Masayuki
M
Hayes
John
J
Park
B Kevin
BK
D001275:ATP Citrate (pro-S)-Lyase / Q000235:genetics; D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D015536:Down-Regulation; D015180:Electrophoresis, Gel, Two-Dimensional; D020869:Gene Expression Profiling; D050356:Lipid Metabolism / Q000235:genetics; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D051267:NF-E2-Related Factor 2 / Q000172:deficiency*; D040901:Proteomics / Q000379:methods*; D015854:Up-Regulation
D000975:Antioxidants; D051267:NF-E2-Related Factor 2; C495636:Nfe2l2 protein, mouse; D001275:ATP Citrate (pro-S)-Lyase
Free Radic Biol Med. 2010 Jan 15;48(2):357-71
19914374
Cancer Res. 2002 Sep 15;62(18):5196-203
12234984
J Biol Chem. 1995 Oct 13;270(41):24468-74
7592662
Nature. 1974 Nov 22;252(5481):326-8
4473724
Adv Enzyme Regul. 1993;33:281-96
8356913
J Biol Chem. 2000 Sep 8;275(36):27694-702
10874044
Proteomics. 2007 Jun;7(12):2121-9
17514684
J Biol Chem. 2000 May 26;275(21):16023-9
10821856
J Biol Chem. 1999 Sep 10;274(37):26071-8
10473555
J Biol Chem. 2000 May 19;275(20):15466-73
10747902
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13943-8
8943040
J Biol Chem. 2001 May 25;276(21):18399-406
11279008
Electrophoresis. 2000 Apr;21(6):1037-53
10786879
Biochem Biophys Res Commun. 2001 Jan 12;280(1):286-92
11162512
Biochem J. 2002 Jul 15;365(Pt 2):405-16
11991805
Blood. 1998 May 1;91(9):3459-66
9558405
J Pharmacol Exp Ther. 2008 May;325(2):655-64
18281592
Carcinogenesis. 2009 Jun;30(6):1024-31
19386581
Methods Mol Biol. 1999;112:487-511
10027273
Nucleic Acids Res. 2003 Jul 1;31(13):3593-6
12824373
Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22
9240432
Anal Biochem. 1976 May 7;72:248-54
942051
Drug Metab Rev. 2007;39(1):235-48
17364885
Peptides. 2004 Sep;25(9):1553-63
15374657
Cancer Res. 1970 Mar;30(3):559-76
4915745
Adv Pharmacol. 1997;38:293-328
8895814
Antioxid Redox Signal. 2007 Nov;9(11):1963-70
17822364
Hepatology. 2000 Aug;32(2):321-33
10915739
Biochem J. 2003 Sep 1;374(Pt 2):337-48
12816537
Kidney Int. 2001 Oct;60(4):1343-53
11576348
Nature. 1999 Dec 16;402(6763):715-20
10617183
Toxicology. 2008 Oct 30;252(1-3):9-16
18721845
Lab Invest. 2008 Oct;88(10):1068-78
18679376
Cancer Res. 2001 Apr 15;61(8):3299-307
11309284
J Biol Chem. 2003 Apr 4;278(14):12029-38
12556532
Proc Natl Acad Sci U S A. 1990 May;87(10):3826-30
2160079
Eur J Biochem. 1992 Mar 1;204(2):491-9
1371749
Carcinogenesis. 2003 Apr;24(4):727-37
12727802
Science. 2009 May 22;324(5930):1076-80
19461003
Science. 1983 Sep 23;221(4617):1256-64
6351251
J Biol Chem. 1990 Aug 25;265(24):14648-53
2387873
Nat Rev Mol Cell Biol. 2006 May;7(5):373-8
16550215
J Biol Chem. 1997 Mar 14;272(11):7445-54
9054446
Hepatology. 2004 May;39(5):1267-76
15122755
Ann Intern Med. 2003 Apr 15;138(8):644-50
12693887
J Biol Chem. 1991 Jun 25;266(18):11632-9
1646813
Biochem J. 2001 Jul 1;357(Pt 1):241-7
11415455
Gastroenterology. 2008 Apr;134(4):1159-68
18395094
Toxicol Sci. 2006 Mar;90(1):111-9
16352618
J Biol Chem. 1999 Nov 19;274(47):33627-36
10559251
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5361-6
9144242
Toxicol Sci. 2001 Jan;59(1):169-77
11134556
Proc Nutr Soc. 2010 Feb;69(1):91-4
19968906
Phytomedicine. 2009 May;16(5):451-5
19131229
J Biol Chem. 2003 Mar 7;278(10):8135-45
12506115
Toxicol Appl Pharmacol. 1995 Nov;135(1):45-57
7482539
Biochem Soc Trans. 2000 Feb;28(2):33-41
10816095
Eur J Pharmacol. 2009 Oct 12;620(1-3):138-44
19698707
Gene. 2002 Jul 10;294(1-2):1-12
12234662
Crit Rev Biochem Mol Biol. 1995;30(6):445-600
8770536
Electrophoresis. 2000 Jun;21(11):2148-61
10892726
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4611-6
11287661
Electrophoresis. 2001 May;22(9):1747-63
11425230
Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G283-94
19926817